Successful ReDiRECt project!
June 2023
Following extensive research, the ReDiRECt project has successfully pinpointed promising drug candidates for repurposing in bladder cancer. These candidates have exhibited anti-cancer effects in pre-clinical models, and further clinical testing is planned.